AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2005
Feb 11, 2005
30786_dirs_2005-02-11_dc730412-58aa-4736-9a58-a50026b2f8f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2005-02-09
Reporting Person: Magni Giovanni (Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-09 | Incentive Stock Option (right to buy) | $57.49 | A | 1000 | Acquired | 2015-02-09 | Bio-Rad A Common Stock (1000) | Direct |
| 2005-02-09 | Non-Qualified Stock Option (right to buy) | $57.49 | A | 4000 | Acquired | 2015-02-09 | Bio-Rad A Common Stock (4000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.75 | 2010-09-19 | Bio-Rad A Common Stock (6500) | 6500 | Direct |
| Incentive Stock Option (right to buy) | $11.94 | 2010-02-02 | Bio-Rad A Common Stock (1000) | 1000 | Direct |
| Incentive Stock Option (right to buy) | $28.61 | 2012-02-06 | Bio-Rad A Common Stock (7000) | 7000 | Direct |
| Incentive Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (4885) | 4885 | Direct |
| Incentive Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (4102) | 4102 | Direct |
| Non-Qualified Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (720) | 720 | Direct |
| Non-Qualified Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (1898) | 1898 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13